Health Care Insurance Bail Out Plan from the start?
Obama Locks Out Single Payer Supporters Call The White House: Let Single Payer In
On Thursday, March 5, 2009, the White House will host a summit on how to reform health care.
The 120 invited guests include lobbyists for various interest groups including the private insurance industry (AHIP), some members of Congress including Senate Finance Committee Chairman Max Baucus, who has already ruled single payer "off the table," and various others concerned with health care.
No single payer advocates have been invited to attend.
Obama Has Met At Least 27 Times With Private Health Care Industry ExecutivesThe records show that, from early February to late June, the White House has invited 15 of the health care and pharmaceutical industry's most powerful players.
Internal Memo Confirms Big Giveaways In White House Deal With Big Pharma
Wellpoint "really did" write the Baucus health plan Fowler learned as a sophomore at the University of Pennsylvania that the United States was the only industrialized country without universal health care, and she decided then to dedicate her professional life to the work.
She first worked for Baucus from 2001 through 2005, playing a key role in negotiating the Medicare Part D prescription drug program. Feeling burned out, she left for the private sector but rejoined Baucus in 2008, sensing that a Democratic-controlled Congress would make progress on overhauling the health care system.
Baucus and Fowler spent a year putting the senator in a position to pursue reform, including holding hearings last summer and issuing a white paper in November. They deliberately avoided releasing legislation in order to send a signal of openness and avoid early attacks.
"People know when Liz is speaking, she is speaking for Baucus," said Dean Rosen, the health policy adviser to former Senate Majority Leader Bill Frist (R-Tenn.).
Health care groups lobby at record paceWASHINGTON — The drug and insurance industries have dramatically amped up their efforts to lobby Congress, spending millions over a three-month period to influence legislation aimed at reshaping the nation's health care system, new reports show.
The Pharmaceutical Research and Manufacturers of America reported nearly $7 million in lobbying expenses from July through September. Overall, the group has spent nearly as much during the first nine months of 2009 as it did during the entire previous year.
Individual drug companies also have sharply increased lobbying. Pfizer, for instance, has spent more than $17 million in lobbying during the first nine months of this year, nearly twice its lobbying budget during the same period in 2008. Pfizer spokeswoman Kristen Neese said the spending reflects a commitment to "making our voice heard."
America's Health Insurance Plans, an association of insurance companies now battling with President Obama over the final shape of health care legislation, racked up $6.3 million in lobbying expenses this year — $1 million more than the same period in 2008, according to lobbying reports filed with Congress and data compiled by the non-partisan CQ MoneyLine.
The sooner people wake up to the fact that the government, congress and the White House included, only cares about the next election, only cares about their campaign money, only cares about the connections they make so they can continue making gobs of money after they leave office and that they
don't care about the lower 99% of us, perhaps then real
change can occur.